Simnotrelvir as a potential treatment for COVID-19
MW McCarthy - Expert Opinion on Pharmacotherapy, 2024 - Taylor & Francis
Introduction Simnotrelvir is a selective 3-chymotrypsin-like oral protease inhibitor with
activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Areas …
activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Areas …